UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21654) 21654
Book Chapter (11) 11
Newsletter (6) 6
Book / eBook (2) 2
Dissertation (2) 2
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (18084) 18084
life sciences & biomedicine (16849) 16849
phosphatidylinositol 3-kinases - metabolism (15214) 15214
humans (13731) 13731
animals (12856) 12856
proto-oncogene proteins c-akt - metabolism (7236) 7236
signal transduction - drug effects (7158) 7158
mice (6219) 6219
phosphatidylinositol 3-kinases - antagonists & inhibitors (6092) 6092
signal transduction (5708) 5708
cell line, tumor (4667) 4667
cell biology (4636) 4636
oncology (4579) 4579
male (4447) 4447
biochemistry & molecular biology (4206) 4206
rats (4122) 4122
female (4057) 4057
phosphorylation (4053) 4053
apoptosis - drug effects (3741) 3741
apoptosis (3739) 3739
cells, cultured (3727) 3727
enzyme inhibitors - pharmacology (3717) 3717
phosphatidylinositol 3-kinases - genetics (2960) 2960
morpholines - pharmacology (2778) 2778
chromones - pharmacology (2637) 2637
cell proliferation - drug effects (2593) 2593
kinases (2583) 2583
cell line (2549) 2549
proteins (2423) 2423
phosphorylation - drug effects (2387) 2387
1-phosphatidylinositol 3-kinase (2214) 2214
signal transduction - physiology (2206) 2206
cancer (2120) 2120
cell survival - drug effects (1907) 1907
androstadienes - pharmacology (1871) 1871
pharmacology & pharmacy (1844) 1844
akt protein (1830) 1830
phosphatidylinositol 3-kinases - physiology (1805) 1805
akt (1788) 1788
research (1775) 1775
dose-response relationship, drug (1742) 1742
blotting, western (1723) 1723
proto-oncogene proteins c-akt (1684) 1684
antineoplastic agents - pharmacology (1683) 1683
protein kinase inhibitors - pharmacology (1644) 1644
enzyme activation - drug effects (1642) 1642
gene expression (1625) 1625
rats, sprague-dawley (1604) 1604
pi3k (1551) 1551
research article (1512) 1512
tor serine-threonine kinases - metabolism (1497) 1497
analysis (1490) 1490
proto-oncogene proteins - metabolism (1483) 1483
mutation (1447) 1447
cell proliferation (1422) 1422
mitogen-activated protein kinases - metabolism (1422) 1422
proto-oncogene proteins c-akt - genetics (1373) 1373
enzyme activation (1312) 1312
neurosciences (1265) 1265
proto-oncogene proteins c-akt - antagonists & inhibitors (1232) 1232
physiology (1227) 1227
science & technology - other topics (1223) 1223
neurosciences & neurology (1221) 1221
insulin - pharmacology (1206) 1206
abridged index medicus (1202) 1202
multidisciplinary sciences (1188) 1188
endocrinology & metabolism (1187) 1187
medicine, research & experimental (1182) 1182
research & experimental medicine (1182) 1182
health aspects (1173) 1173
physiological aspects (1168) 1168
cell movement - drug effects (1154) 1154
protein-serine-threonine kinases - metabolism (1149) 1149
transfection (1139) 1139
genetic aspects (1103) 1103
tumor cells, cultured (1102) 1102
immunology (1070) 1070
nf-kappa b - metabolism (1066) 1066
mice, inbred c57bl (1065) 1065
map kinase signaling system - drug effects (1062) 1062
tumors (1056) 1056
medicine (1024) 1024
time factors (1024) 1024
rodents (1014) 1014
middle aged (989) 989
cell cycle (964) 964
breast cancer (952) 952
phosphatidylinositol 3-kinases (948) 948
biology (947) 947
disease models, animal (931) 931
extracellular signal-regulated map kinases - metabolism (930) 930
protein-serine-threonine kinases (928) 928
hematology (927) 927
rna, messenger - metabolism (897) 897
cell growth (891) 891
adult (877) 877
wortmannin (877) 877
care and treatment (876) 876
insulin (857) 857
signaling (854) 854
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21564) 21564
Chinese (212) 212
Japanese (107) 107
Russian (24) 24
Portuguese (16) 16
French (14) 14
German (8) 8
Dutch (3) 3
Hungarian (3) 3
Korean (3) 3
Spanish (3) 3
Ukrainian (3) 3
Italian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular cancer therapeutics, ISSN 1538-8514, 07/2009, Volume 8, Issue 7, pp. 1725 - 1738
Journal Article
Nature (London), ISSN 1476-4687, 02/2017, Volume 542, Issue 7642, pp. 489 - 493
...). In addition, through off-target activity, AID has a much broader effect on genomic instability by initiating oncogenic chromosomal translocations and mutations involved in the development and progression of lymphoma(2... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Isoquinolines - adverse effects | Class I Phosphatidylinositol 3-Kinases - metabolism | Humans | Lymphoma, Mantle-Cell - pathology | Phosphatidylinositol 3-Kinases - metabolism | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Translocation, Genetic - drug effects | Isoquinolines - pharmacology | Antineoplastic Agents - adverse effects | Genomic Instability - drug effects | Female | Antineoplastic Agents - pharmacology | Purines - adverse effects | B-Lymphocytes - pathology | Immunoglobulin Class Switching - drug effects | Somatic Hypermutation, Immunoglobulin - drug effects | Lymphoma, Mantle-Cell - genetics | B-Lymphocytes - metabolism | Quinazolinones - pharmacology | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Enzyme Inhibitors - adverse effects | B-Lymphocytes - enzymology | Purines - pharmacology | Enzyme Inhibitors - pharmacology | Pyrimidines - pharmacology | Class I Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | B-Lymphocytes - drug effects | Animals | Agammaglobulinaemia Tyrosine Kinase | Cytidine Deaminase - metabolism | Pyrimidines - adverse effects | Cell Line, Tumor | Mice | Immunoglobulin Heavy Chains - genetics | Quinazolinones - adverse effects | Recombination, Genetic - drug effects | Protein-Tyrosine Kinases - antagonists & inhibitors | Index Medicus
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 10/2009, Volume 101, Issue 19, pp. 1308 - 1324
The monoclonal antibodies panitumumab and cetuximab that target the epidermal growth factor receptor (EGFR) have expanded the range of treatment options for... 
Life Sciences & Biomedicine | Oncology | Science & Technology | PTEN Phosphohydrolase - drug effects | Predictive Value of Tests | Proto-Oncogene Proteins p21(ras) - genetics | Colorectal Neoplasms - genetics | Humans | Antibodies, Monoclonal - therapeutic use | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | Colorectal Neoplasms - drug therapy | Phosphatidylinositol 3-Kinases - drug effects | Biomarkers, Tumor - metabolism | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Cetuximab | Odds Ratio | PTEN Phosphohydrolase - genetics | Proto-Oncogene Proteins - drug effects | Antibodies, Monoclonal - pharmacology | Proto-Oncogene Proteins - genetics | Randomized Controlled Trials as Topic | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Proto-Oncogene Proteins p21(ras) - drug effects | Animals | Class I Phosphatidylinositol 3-Kinases | Mutation - drug effects | Proto-Oncogene Proteins B-raf - drug effects | Proto-Oncogene Proteins B-raf - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Colorectal Neoplasms - pathology | Neoplasm Staging | Research Design | Usage | Care and treatment | Prognosis | Gene mutations | Colorectal cancer | Monoclonal antibodies | Development and progression | Genetic aspects | Research | Biological markers | Health aspects | Biomarkers | Cancer therapies | Clinical outcomes | Index Medicus | Review
Journal Article
The Journal of cell biology, ISSN 1540-8140, 10/2001, Volume 155, Issue 1, pp. 19 - 26
Journal Article
Frontiers in immunology, ISSN 1664-3224, 02/2018, Volume 9, pp. 237 - 237
The phosphatidylinositol-3-kinase (PI3K)/Akt pathway is important for multiple stages of herpesvirus replication including virus entry, replication, latency,... 
APDS | Cytomegalovirus | Phosphatidylinositol-3-kinase | PASLI | PIK3CD | Epstein-Barr virus | Akt | PIK3R1 | Life Sciences & Biomedicine | Immunology | Science & Technology | Class I Phosphatidylinositol 3-Kinases - genetics | Class I Phosphatidylinositol 3-Kinases - metabolism | Humans | Immunosuppressive Agents - therapeutic use | Cytomegalovirus Infections - immunology | Phosphatidylinositol 3-Kinases - metabolism | Class I Phosphatidylinositol 3-Kinases - immunology | Cytomegalovirus Infections - genetics | Phosphatidylinositol 3-Kinases - immunology | Herpesvirus 4, Human - isolation & purification | T-Lymphocytes - metabolism | Cytomegalovirus Infections - virology | Epstein-Barr Virus Infections - genetics | Class I Phosphatidylinositol 3-Kinases - drug effects | Gain of Function Mutation | Immunologic Deficiency Syndromes - immunology | Proto-Oncogene Proteins c-akt - metabolism | Immunosuppressive Agents - pharmacology | Cytomegalovirus - isolation & purification | Genetic Predisposition to Disease | Epstein-Barr Virus Infections - virology | Epstein-Barr Virus Infections - immunology | Herpesvirus 4, Human - immunology | Viremia - genetics | Viremia - drug therapy | Immunologic Deficiency Syndromes - virology | Class I Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Epstein-Barr Virus Infections - drug therapy | Phosphatidylinositol 3-Kinases - genetics | Cytomegalovirus - immunology | Proto-Oncogene Proteins c-akt - immunology | Viremia - virology | Cytomegalovirus Infections - drug therapy | Immunologic Deficiency Syndromes - genetics | T-Lymphocytes - immunology | Viremia - immunology | Index Medicus | phosphatidylinositol-3-kinase
Journal Article
Blood, ISSN 1528-0020, 03/2013, Volume 121, Issue 12, pp. 2274 - 2284
The increased expression of PI3K p110α in mantle cell lymphoma, particularly at relapse, suggests a role for p110α in disease progression. A high PIK3CA/PIK3CD... 
Life Sciences & Biomedicine | Hematology | Science & Technology | Recurrence | Humans | Lymphoma, Mantle-Cell - pathology | Quinazolinones - administration & dosage | Substrate Specificity | Phosphatidylinositol 3-Kinases - metabolism | Gene Expression Regulation, Enzymologic - physiology | Purines - administration & dosage | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Antineoplastic Combined Chemotherapy Protocols - pharmacology | DNA Mutational Analysis | Purines - therapeutic use | Gene Expression Regulation, Neoplastic - drug effects | Gene Expression Regulation, Neoplastic - physiology | Lymphoma, Mantle-Cell - genetics | Lymphoma, Mantle-Cell - metabolism | Gene Expression Regulation, Neoplastic - genetics | Quinazolinones - pharmacology | Purines - pharmacology | Lymphoma, Mantle-Cell - drug therapy | Treatment Outcome | Phosphatidylinositol 3-Kinases - genetics | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Class I Phosphatidylinositol 3-Kinases | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Cell Line, Tumor | Phosphatidylinositol 3-Kinases - physiology | Signal Transduction - physiology | Protein Kinase Inhibitors - pharmacology | Quinazolinones - therapeutic use | Index Medicus | Abridged Index Medicus | Lymphoid Neoplasia
Journal Article